Fitzgerald Industries International, Inc. ACCN4 Blocking Peptide 33R-6782

Description
A synthetic peptide for use as a blocking control in assays to test for specificity of ACCN4 antibody, catalog no. 70R-5078 Background: ACCN4 belongs to the superfamily of acid-sensing ion channels, which are proton-gated, amiloride-sensitive sodium channels. These channels have been implicated in synaptic transmission, pain perception as well as mechanoperception. ACCN4 is predominantly expressed in the pituitary gland, and might be a candidate for paroxysmal dystonic choreoathetosis (PDC), a movement disorder.
Description
A synthetic peptide for use as a blocking control in assays to test for specificity of ACCN4 antibody, catalog no. 70R-5078 Background: ACCN4 belongs to the superfamily of acid-sensing ion channels, which are proton-gated, amiloride-sensitive sodium channels. These channels have been implicated in synaptic transmission, pain perception as well as mechanoperception. ACCN4 is predominantly expressed in the pituitary gland, and might be a candidate for paroxysmal dystonic choreoathetosis (PDC), a movement disorder.

Suppliers

Company
Product
Description
Supplier Links
Fitzgerald Industries International, Inc.
Acton, MA, USA
ACCN4 Blocking Peptide
33R-6782
ACCN4 Blocking Peptide 33R-6782
A synthetic peptide for use as a blocking control in assays to test for specificity of ACCN4 antibody, catalog no. 70R-5078 Background: ACCN4 belongs to the superfamily of acid-sensing ion channels, which are proton-gated, amiloride-sensitive sodium channels. These channels have been implicated in synaptic transmission, pain perception as well as mechanoperception. ACCN4 is predominantly expressed in the pituitary gland, and might be a candidate for paroxysmal dystonic choreoathetosis (PDC), a movement disorder.

A synthetic peptide for use as a blocking control in assays to test for specificity of ACCN4 antibody, catalog no. 70R-5078
Background:
ACCN4 belongs to the superfamily of acid-sensing ion channels, which are proton-gated, amiloride-sensitive sodium channels. These channels have been implicated in synaptic transmission, pain perception as well as mechanoperception. ACCN4 is predominantly expressed in the pituitary gland, and might be a candidate for paroxysmal dystonic choreoathetosis (PDC), a movement disorder.

Supplier's Site

Technical Specifications

  Fitzgerald Industries International, Inc.
Product Category Biological Materials
Product Number 33R-6782
Product Name ACCN4 Blocking Peptide
Unlock Full Specs
to access all available technical data

Similar Products